Ressources
Publications
Paediatric Liver Cancer
A preclinical platform of mouse-transplanted human pediatric liver tumors to evaluate the efficacy of conventional and innovative anticancer therapy
Publications
Paediatric Liver Cancer
Liver cancer patient-derived xenografts to improve disease management in childhood and adolescence: perspectives and challenges of personalized medicine
Publications
Paediatric Liver Cancer
A panel of pediatric liver cancer patient-derived xenografts to improve stratification of children with hepatoblastoma
Publications
2D PDX-derived primary cultures
A new and fast in vitro screen to predict in vivo drug efficacy using cell primary culture from patient derived tumor established xenografts
publications
Paediatric Liver Cancer
Liver cancer patient-derived xenografts to improve disease management in childhood and adolescence: perspectives and challenges of personalized medicine
publications
Paediatric Liver Cancer
A panel of pediatric liver cancer patient-derived xenografts to improve stratification of children with hepatoblastoma
publications
2D PDX-derived primary cultures
A new and fast in vitro screen to predict in vivo drug efficacy using cell primary culture from patient derived tumor established xenografts
publications
Liver Cancer
Myc Target miRs and Liver Cancer: Small Molecules to Get Myc Sick
01Conferences & events
01.24.23
XenTech will attend the DDR inhibitors Summit 2023 (Boston, Jan. 24-26)
Our Head of R&D Oliver Déas will be delighted to discuss with you as he'll be attending in person.
04.08.22
XenTech exhibits at AACR Annual Meeting (New Orleans, Apr.8-13 2022)
We'll be exhibiting at AACR New Orleans from Apr.8th 2022, stop by our booth to chat with us (at last!)
10.05.21
XenTech live at AACR Spotlight Series
XenTech uncovers its unique dedication into PDX field to AACR attendees on Oct. 5th 2021